Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill

NCT01317381 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.

NCT NCT01317381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01317381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill
Lead sponsor
University of Zurich
Phase
Observational
Overall status
Unknown status
Start date
May 31, 2010
Completion date
May 31, 2011
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critically ill patients